Skip to Main Content

Paper Details

PARP inhibitors synergize with gemcitabine by potentiating DNA damage in non-small-cell lung cancer.
Int J Cancer
31
2019
Author NameAffiliation
Shiaw-Yih LinThe University of Texas MD Anderson Cancer Center
Daniel J McGrailThe University of Texas MD Anderson Cancer Center
  • 1 - 2

Datasets

Release 1.2